Together we will beat cancer

Donate

Common anti-inflammatory drug could boost cancer immunotherapy

Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.

Read More

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

Read More

Scientists develop next-generation immunotherapy now entering early phase clinical trials

Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.

Read More

Removing cancer’s protective barrier could boost immunotherapy treatments

Scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system.

Read More

Immune-stimulating injection turns tumours into ‘cancer vaccine factories’ in mice

Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice.

Read More

Immunotherapy trial shows promise for some women with an aggressive breast cancer

An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer.

Read More

Urine liquid biopsies could help monitor bladder cancer treatment

Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment.

Read More

Liver cancer: UK’s fastest rising cause of cancer death to be tackled

A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK.

Read More

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

Read More

Viruses may boost immunotherapy in brain and breast cancer

Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies.

Read More